AJP - Lung Columbus Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol (May 11, 2007). doi:10.1152/ajplung.00112.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/2/L259    most recent
00112.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andreeva, A. V
Right arrow Articles by Voyno-Yasenetskaya, T. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andreeva, A. V
Right arrow Articles by Voyno-Yasenetskaya, T. A.
Submitted on March 23, 2007
Accepted on May 9, 2007

Regulation of Surfactant Secretion in Alveolar Type II cells

Alexandra V Andreeva1, Mikhail A Kutuzov1, and Tatyana A. Voyno-Yasenetskaya1*

1 Pharmacology, University of Illinois, Chicago, Illinois, United States

* To whom correspondence should be addressed. E-mail: tvy{at}uic.edu.

Molecular mechanisms of surfactant delivery to the air/liquid interface in the lung, which is crucial to lower the surface tension, have been studied for over two decades. Lung surfactant is synthesized in the alveolar type II cells. Its delivery to the cell surface is preceded by surfactant component synthesis, packaging into specialized organelles termed lamellar bodies, delivery to the apical plasma membrane and fusion. Secreted surfactant undergoes re-uptake, intracellular processing and finally re-secretion of recycled material. This review focuses on the mechanisms of delivery of surfactant components to and their secretion from lamellar bodies. Lamellar bodies-independent secretion is also considered. Signal transduction pathways involved in regulation of these processes are discussed, as well as disorders associated with their malfunction.




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
L. Gahlot, F. H. Y. Green, A. Rigaux, J. M. Schneider, and S. U. Hasan
Role of vagal innervation on pulmonary surfactant system during fetal development
J Appl Physiol, May 1, 2009; 106(5): 1641 - 1649.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
O. Bardou, N. T. N. Trinh, and E. Brochiero
Molecular diversity and function of K+ channels in airway and alveolar epithelial cells
Am J Physiol Lung Cell Mol Physiol, February 1, 2009; 296(2): L145 - L155.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
I. Garcia-Verdugo, A. Ravasio, E. G. de Paco, M. Synguelakis, N. Ivanova, J. Kanellopoulos, and T. Haller
Long-term exposure to LPS enhances the rate of stimulated exocytosis and surfactant secretion in alveolar type II cells and upregulates P2Y2 receptor expression
Am J Physiol Lung Cell Mol Physiol, October 1, 2008; 295(4): L708 - L717.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.